Prospectus Supplement Filed Pursuant to Rule 424(b)(3)
(to Prospectus dated April 22, 2005) Registration No. 333-123862
AMERICAN EQUITY INVESTMENT LIFE HOLDING COMPANY
$250,000,000 of 5.25% Contingent Convertible Senior Notes due 2024
$10,000,000 of Series B 5.25% Contingent Convertible Senior Notes due 2024
and
Shares of Common Stock Issuable Upon Conversion of the Notes
This prospectus supplement supplements the prospectus dated April 22,
2005, as supplemented by the prospectus supplements dated May 2, 2005, May 11,
2005, May 25, 2005, June 8, 2005, July 1, 2005, July 22, 2005, August 23, 2005
and September 13, 2005, relating to the resale by certain of our
securityholders of up to $250,000,000 of our 5.25% Contingent Convertible
Senior Notes due 2024, $10,000,000 of our Series B 5.25% Contingent Convertible
Senior Notes due 2024 and the shares of our common stock issuable upon
conversion of the notes. You should read this prospectus supplement in
conjunction with the prospectus. This prospectus supplement is qualified by
reference to the prospectus, except to the extent that the information in this
prospectus supplement supersedes the information contained in the prospectus.
The information appearing under the heading "Selling Securityholders"
in the prospectus is hereby amended by the addition or substitution, as
applicable, of the following:
Aggregate
Principal Percentage of Number of Shares
Amount Aggregate Principal of Common Stock Percentage of
of Notes That Amount of Notes That May Be Common Stock
Name May Be Sold Outstanding Sold(1) Outstanding(2)
-------------------------------------------- ------------- ------------------- ----------------- --------------
Argent Classic Convertible Arbitrage Fund
(Bermuda) Ltd. .......................... 2,990,000 1.15% 206,634 *
Argent Classic Convertible Arbitrage Fund
L.P. .................................... 530,000 * 36,627 *
Argent Classic Convertible Arbitrage Fund
II, L.P. ................................ 130,000 * 8,984 *
Lyxor Convertible Arb. Fund................. 697,000 * 48,168 *
Xavex Convertible Arbitrage 10 Fund......... 350,000 * 24,187 *
---------------
* Represents less than 1%.
(1) Assumes conversion of all of the holder's notes at a conversion rate of
69.1085 shares of common stock per $1,000 principal amount at maturity of
the notes. This conversion rate is subject to adjustment, however, as
described under "Description of the Notes -- Conversion Rights." As a
result, the number of shares of common stock issuable upon conversion of
the notes may increase or decrease in the future.
(2) Calculated based on Rule 13d-3(d)(i) of the Securities Exchange Act of
1934, as amended, using 38,375,157 shares of common stock outstanding as
of February 28, 2005. In calculating this amount for each holder, we
treated as outstanding the number of shares of common stock issuable upon
conversion of all of that holder's notes, but we did not assume conversion
of any other holder's notes.
Investing in the notes and our common stock issuable
upon their conversion involves risks. See "Risk
Factors" beginning on page 7 of the prospectus.
-----------------------------------------------------------------
Neither the Securities and Exchange Commission nor any state
securities commission has approved or disapproved of these
securities or passed upon the adequacy of this prospectus. Any
representation to the contrary is a criminal offense.
-----------------------------------------------------------------
__________
The date of this prospectus supplement is October 4, 2005.